Investigating Effect of Rapamycin and Metformin on Angiogenesis in Hepatocellular Carcinoma Cell Line.

Rastegar, Mandana; Marjani, Haji-Amin; Yazdani, Yaghoub; Shahbazi, Majid; Golalipour, Masoud; Farazmandfar, Touraj

Rastegar, Mandana; Marjani, Haji-Amin; Yazdani, Yaghoub; Shahbazi, Majid; Golalipour, Masoud; Farazmandfar, Touraj.

Afiliación

Rastegar M; Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Marjani HA; Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Yazdani Y; Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Shahbazi M; Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Golalipour M; Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Farazmandfar T; Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

Adv Pharm Bull ; 8(1): 63-68, 2018 Mar.

Article en En | MEDLINE | ID: mdl-29670840

Palabras clave

Hepatocellular carcinoma; Metformin; Rapamycin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Adv Pharm Bull Año: 2018 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google